Additionally, it has been demonstrated that targeting VEGF or VEGF-R decreases the number of immunosuppressive cells, such as regulatory T cells and myeloid-derived suppressor cells (MDSCs), in tumor models and patients with cancer [14]. Here, KDR is linked to cancer.